WHO ICTRP trial
PsiConnect: Brain Connectivity and Context under Psilocybin
ACTRN12621001375842 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12621001375842 |
|---|---|
| Public title | PsiConnect: Brain Connectivity and Context under Psilocybin |
| Scientific title | Investigating the impact of of Psilocybin and guided meditation on brain connectivity in healthy adults |
| Primary sponsor | Monash University |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | Neural mechanisms of psilocybin induced altered-states of consciousness; Neural mechanisms of psilocybin induced altered-states of consciousness;Mental Health - Studies of normal psychology, cognitive function and behaviour |
| Interventions | - 60 healthy participants will undergo fMRI (approx. 60 minutes) followed by and EEG (approx. 90 minutes hour) scans at two time points: [1] Approximately 1 week before oral capsule administration of 19mg psilocybin (baseline), [2] Day of… |
| Registration date | Nov 10, 2021 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: